Alcohol consumption and incidence of prostate cancer among Chinese people: A systematic review and meta-analysis

Jinhui Zhao, D. Gao, Yanhui Li, T. Stockwell, Jun Ma
{"title":"Alcohol consumption and incidence of prostate cancer among Chinese people: A systematic review and meta-analysis","authors":"Jinhui Zhao, D. Gao, Yanhui Li, T. Stockwell, Jun Ma","doi":"10.7895/ijadr.263","DOIUrl":null,"url":null,"abstract":"Aims: Meta-analyses have suggested a dose-response relationship between level of alcohol use and risk of prostate cancer, but the populations in the included studies are predominantly Caucasian. Many Chinese language studies have not been included in published reviews and/or meta-analyses. The present meta–analysis accessed research reports in both English and Chinese language sources in order to investigate this relationship specifically among Chinese people. Methods: Searches in five large Chinese biomedical bibliographic databases were made for case–control and cohort studies of alcohol consumption and prostate cancer incidence and death (ICD–10: C61) up to May 2017. Studies were coded for design, outcome, drinker and non-drinkers, extent of control for confounding and other study characteristics. Mixed models were used to estimate relative risk (RR) of incidence or death from prostate cancer due to alcohol consumption with study level controls for designs, drinker bias and types of drinkers. Findings: A total of 415 studies were identified of which 25 (20 in Chinese from five Chinese databases and 5 in English from published meta-analyses) satisfied inclusion criteria providing 36 risk estimates of prostate cancer for drinkers versus non-drinkers. There was a total of 36 OR estimates; 27 using patients as controls and 9 using healthy people. Nine studies (14 OR estimates) specified reference abstainers as “never drank” or “no drinking”. Adjusted RR estimates indicated a significantly increased risk of prostate cancer among drinkers (RR=1.46, 95% CI: 1.40 – 1.52, t-test P<0.001) compared to non-drinkers. Dose-response relationships (t-test P<0.001) were evident in three studies that assessed level of alcohol intake. Conclusions: There is a significantly higher risk of prostate cancer incidence among Chinese drinkers than non-drinkers, with some evidence of a dose-response relationship. However, almost all the identified studies suffered from former and/or occasional drinker biases. Few studies had adequate measures of level of alcohol intake and further well-designed studies are required. Prostate cancer is the development of cancer in the prostate, a walnut–sized gland in men that surrounds the top of the urethra and which produces seminal fluid (Bostwick, Crawford, Higano, & Roach, 2004). Its growth and functions are controlled by male hormones such as testosterone. Prostate cancer is the second most common cancer in men worldwide. Around 1.1 million cases were recorded in 2012, accounting for 15% of all new cases of cancer in men (Forman & Ferlay, 2014). It is the fifth most common cause of cancer death in men worldwide. There have been marked geographic, racial and ethnic variations in incidence and mortality of prostate cancer variously due to underdiagnosis, underreporting, differences in screening practices, differences in health-care access, gaps in knowledge and awareness and prevalence level of risk factors such as alcohol consumption (Hsing & Devesa, 2001; Taitt, 2018). It is most commonly diagnosed in high–income western countries, where screening is common. However, the incidence of prostate cancer appears to be increasing in Asian countries such as Japan and China even though prostate‐specific antigen (PSA) testing is not often used (Baade, Youlden, & Krnjacki, 2009). It has been recognized IJADR International Journal of Alcohol and Drug Research The Official Journal of the Kettil Bruun Society for Social and Epidemiological Research on Alcohol 13 Jinhui Zhao and Di Gao et al. –––––– IJADR 8(1) –––––– that prostate cancer is a currently common disease among Chinese males. The incidence rate was about 9.8 per 100,000 males in 2014, a significantly increased trend since 2008 (National Health Commission of the People's Republic of China, 2019; Ye & Zhu, 2015). Therefore, prostate cancer as a chronic disease has become an important public health concern in developing countries such as China. The risk factors for prostate cancer that can be considered established include age, race/ethnicity and family history (Gann, 2002). Many observational studies conducted mainly in Caucasian populations have investigated alcohol consumption as a risk factor for prostate cancer. Conclusions from these studies and of reviews have been conflicting with some finding increased risk of prostate cancer (Hayes et al., 1996; Sesso, Paffenbarger, & Lee, 2001; Watters, Park, Hollenbeck, Schatzkin, & Albanes, 2010), or decreased risk (Dagnelie, Schuurman, Goldbohm, & Van den Brandt, 2004) and others finding no relationship (Hiatt, Armstrong, Klatsky, & Sidney, 1994; Longnecker, 1995; Morton, Griffiths, & Blacklock, 1996; Stemmermann, Nomura, Chyou, & Yoshizawa, 1990; Tavani, Negri, Franceschi, Talamini, & Lavecchia, 1994; Vandergulden, Verbeek, & Kolk, 1994). Over the past few decades there have been several reviews and meta–analyses conducted to examine the association of prostate cancer with alcohol consumption (Bagnardi, Blangiardo, La Vecchia, & Corrao, 2001; Breslow & Weed, 1998; Dagnelie et al., 2004; Dennis, 2000; Fillmore, Chikritzhs, Stockwell, Bostrom, & Pascal, 2009; Li, Yang, & Cao, 2011; Longnecker, 1995; Morton et al., 1996; Rota et al., 2012; Zhao, Stockwell, Roemer, & Chikritzhs, 2016) because of inconsistent results regarding the relationship between prostate cancer and alcohol consumption across individual studies. The most recent one, mainly based on the studies conducted in western countries shows a significant dose-response relationship (Zhao et al., 2016). Because prior reviews and/or meta-analyses were conducted based on the studies searched and analyzed in English journals from English databases, these studies were mainly conducted with Caucasian populations. These published reviews and/or meta-analyses included few studies conducted in non-Caucasian populations such as Asians. Few studies conducted in Asian populations have been published in English journals and thus included in published reviews and meta-analyses. Over years, only six studies conducted on the Chinese population in China were included in published reviews and meta-analyses and one of these six studies was published in a Chinese journal (Breslow & Weed, 1998; Dennis, 2000; Wei, Tang, Yang, Zhan, & Yin, 1994) and other five in English journals (Hsing et al., 1994; Jian, Xie, Lee, & Binns, 2004; Lee et al., 1998; Li et al., 2008; Yang et al., 2006). Meta-analysis by Li et al. (2011) included only four case-control studies of prostate cancer and alcohol consumption and found no relationship (Li et al., 2011). Among these six reviewed studies (nine risk estimates) in Chinese populations living in mainland China, only one shows a significantly increased risk when healthy people were treated as controls (Hsing et al., 1994). No studies were conducted on Chinese populations in other countries or regions. It is unclear whether or not those studies published in Chinese journals or non-English journals that cannot be located in English databases show different results as the risk estimates in published metaanalyses. Biological studies suggested that the effects of alcohol use on incidence of prostate cancer differed by race and/or environment because encoded enzymes involved in metabolizing alcohol differ by race. Alcohol is metabolized in the body mainly by the liver. Most of the ethanol in the body is broken down in the liver by an enzyme called alcohol dehydrogenase (ADH) which transforms ethanol into a toxic compound called acetaldehyde, a known carcinogen (Edenberg, 2007). Acetaldehyde is quickly broken down to a less toxic compound called acetate (Edenberg, 2007) by another enzyme called acetate dehydrogenase (ALDH). Acetate is then broken down to carbon dioxide and water for easy elimination (Edenberg, 2007). A person’s risk of alcohol-related cancers is influenced by their genes that encode enzymes involved in metabolizing alcohol (DruesnePecollo et al., 2009). Many East Asian people carry a version of the gene for ADH that codes for a “superactive” form of the enzyme. This superactive ADH enzyme speeds the conversion of alcohol to toxic acetaldehyde. Among people of Japanese descent, those who have this form of ADH have a higher risk of pancreatic cancer than those with the more common form of ADH (Kanda et al., 2009). Research finds that genes encoding enzymes such as ADH1B involved in alcohol metabolism are polymorphic and that the superactive ADH1B*2 allele is highly prevalent (54-96%) among East Asians (Goedde et al., 1992) but relatively rare among Caucasians (1-23%). The less active ADH1B*1 is a risk factor for alcoholism in both Asians and Caucasians (Zintzaras, 2006; Zintzaras, Stefanidis, Santos, & Vidal, 2006). Some people of East Asian descent carry a variant of the gene for ALDH2 that encodes a defective form of the enzyme. In people who produce the defective enzyme, acetaldehyde builds up when they drink alcohol. The accumulation of acetaldehyde has such unpleasant effects that most people who have inherited the ALDH2 variant are unable to consume large amounts of alcohol and therefore have a low risk of developing alcohol-related cancers such as prostate cancer. Genetic differences in these enzymes suggest that the effect of alcohol consumption on prostate cancer maybe different among Asians such as Chinese from that found among Caucasians and it is thus necessary to investigate the relationship between prostate cancer and alcohol consumption in non-Caucasians, for instance in Chinese populations. There has been a marked increase in the numbers of cancers diagnosed in China between 2000 and 2011 (Chen et al., 2016). Much of this is explained by the aging and growth of the population. Other factors that may have contributed to the increase in the burden of cancer include increases in the prevalence of unhealthy behaviors or cancer‐related lifestyle and improvements in disease awareness, detection services, and data comp","PeriodicalId":162336,"journal":{"name":"The International Journal of Alcohol and Drug Research","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The International Journal of Alcohol and Drug Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7895/ijadr.263","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Aims: Meta-analyses have suggested a dose-response relationship between level of alcohol use and risk of prostate cancer, but the populations in the included studies are predominantly Caucasian. Many Chinese language studies have not been included in published reviews and/or meta-analyses. The present meta–analysis accessed research reports in both English and Chinese language sources in order to investigate this relationship specifically among Chinese people. Methods: Searches in five large Chinese biomedical bibliographic databases were made for case–control and cohort studies of alcohol consumption and prostate cancer incidence and death (ICD–10: C61) up to May 2017. Studies were coded for design, outcome, drinker and non-drinkers, extent of control for confounding and other study characteristics. Mixed models were used to estimate relative risk (RR) of incidence or death from prostate cancer due to alcohol consumption with study level controls for designs, drinker bias and types of drinkers. Findings: A total of 415 studies were identified of which 25 (20 in Chinese from five Chinese databases and 5 in English from published meta-analyses) satisfied inclusion criteria providing 36 risk estimates of prostate cancer for drinkers versus non-drinkers. There was a total of 36 OR estimates; 27 using patients as controls and 9 using healthy people. Nine studies (14 OR estimates) specified reference abstainers as “never drank” or “no drinking”. Adjusted RR estimates indicated a significantly increased risk of prostate cancer among drinkers (RR=1.46, 95% CI: 1.40 – 1.52, t-test P<0.001) compared to non-drinkers. Dose-response relationships (t-test P<0.001) were evident in three studies that assessed level of alcohol intake. Conclusions: There is a significantly higher risk of prostate cancer incidence among Chinese drinkers than non-drinkers, with some evidence of a dose-response relationship. However, almost all the identified studies suffered from former and/or occasional drinker biases. Few studies had adequate measures of level of alcohol intake and further well-designed studies are required. Prostate cancer is the development of cancer in the prostate, a walnut–sized gland in men that surrounds the top of the urethra and which produces seminal fluid (Bostwick, Crawford, Higano, & Roach, 2004). Its growth and functions are controlled by male hormones such as testosterone. Prostate cancer is the second most common cancer in men worldwide. Around 1.1 million cases were recorded in 2012, accounting for 15% of all new cases of cancer in men (Forman & Ferlay, 2014). It is the fifth most common cause of cancer death in men worldwide. There have been marked geographic, racial and ethnic variations in incidence and mortality of prostate cancer variously due to underdiagnosis, underreporting, differences in screening practices, differences in health-care access, gaps in knowledge and awareness and prevalence level of risk factors such as alcohol consumption (Hsing & Devesa, 2001; Taitt, 2018). It is most commonly diagnosed in high–income western countries, where screening is common. However, the incidence of prostate cancer appears to be increasing in Asian countries such as Japan and China even though prostate‐specific antigen (PSA) testing is not often used (Baade, Youlden, & Krnjacki, 2009). It has been recognized IJADR International Journal of Alcohol and Drug Research The Official Journal of the Kettil Bruun Society for Social and Epidemiological Research on Alcohol 13 Jinhui Zhao and Di Gao et al. –––––– IJADR 8(1) –––––– that prostate cancer is a currently common disease among Chinese males. The incidence rate was about 9.8 per 100,000 males in 2014, a significantly increased trend since 2008 (National Health Commission of the People's Republic of China, 2019; Ye & Zhu, 2015). Therefore, prostate cancer as a chronic disease has become an important public health concern in developing countries such as China. The risk factors for prostate cancer that can be considered established include age, race/ethnicity and family history (Gann, 2002). Many observational studies conducted mainly in Caucasian populations have investigated alcohol consumption as a risk factor for prostate cancer. Conclusions from these studies and of reviews have been conflicting with some finding increased risk of prostate cancer (Hayes et al., 1996; Sesso, Paffenbarger, & Lee, 2001; Watters, Park, Hollenbeck, Schatzkin, & Albanes, 2010), or decreased risk (Dagnelie, Schuurman, Goldbohm, & Van den Brandt, 2004) and others finding no relationship (Hiatt, Armstrong, Klatsky, & Sidney, 1994; Longnecker, 1995; Morton, Griffiths, & Blacklock, 1996; Stemmermann, Nomura, Chyou, & Yoshizawa, 1990; Tavani, Negri, Franceschi, Talamini, & Lavecchia, 1994; Vandergulden, Verbeek, & Kolk, 1994). Over the past few decades there have been several reviews and meta–analyses conducted to examine the association of prostate cancer with alcohol consumption (Bagnardi, Blangiardo, La Vecchia, & Corrao, 2001; Breslow & Weed, 1998; Dagnelie et al., 2004; Dennis, 2000; Fillmore, Chikritzhs, Stockwell, Bostrom, & Pascal, 2009; Li, Yang, & Cao, 2011; Longnecker, 1995; Morton et al., 1996; Rota et al., 2012; Zhao, Stockwell, Roemer, & Chikritzhs, 2016) because of inconsistent results regarding the relationship between prostate cancer and alcohol consumption across individual studies. The most recent one, mainly based on the studies conducted in western countries shows a significant dose-response relationship (Zhao et al., 2016). Because prior reviews and/or meta-analyses were conducted based on the studies searched and analyzed in English journals from English databases, these studies were mainly conducted with Caucasian populations. These published reviews and/or meta-analyses included few studies conducted in non-Caucasian populations such as Asians. Few studies conducted in Asian populations have been published in English journals and thus included in published reviews and meta-analyses. Over years, only six studies conducted on the Chinese population in China were included in published reviews and meta-analyses and one of these six studies was published in a Chinese journal (Breslow & Weed, 1998; Dennis, 2000; Wei, Tang, Yang, Zhan, & Yin, 1994) and other five in English journals (Hsing et al., 1994; Jian, Xie, Lee, & Binns, 2004; Lee et al., 1998; Li et al., 2008; Yang et al., 2006). Meta-analysis by Li et al. (2011) included only four case-control studies of prostate cancer and alcohol consumption and found no relationship (Li et al., 2011). Among these six reviewed studies (nine risk estimates) in Chinese populations living in mainland China, only one shows a significantly increased risk when healthy people were treated as controls (Hsing et al., 1994). No studies were conducted on Chinese populations in other countries or regions. It is unclear whether or not those studies published in Chinese journals or non-English journals that cannot be located in English databases show different results as the risk estimates in published metaanalyses. Biological studies suggested that the effects of alcohol use on incidence of prostate cancer differed by race and/or environment because encoded enzymes involved in metabolizing alcohol differ by race. Alcohol is metabolized in the body mainly by the liver. Most of the ethanol in the body is broken down in the liver by an enzyme called alcohol dehydrogenase (ADH) which transforms ethanol into a toxic compound called acetaldehyde, a known carcinogen (Edenberg, 2007). Acetaldehyde is quickly broken down to a less toxic compound called acetate (Edenberg, 2007) by another enzyme called acetate dehydrogenase (ALDH). Acetate is then broken down to carbon dioxide and water for easy elimination (Edenberg, 2007). A person’s risk of alcohol-related cancers is influenced by their genes that encode enzymes involved in metabolizing alcohol (DruesnePecollo et al., 2009). Many East Asian people carry a version of the gene for ADH that codes for a “superactive” form of the enzyme. This superactive ADH enzyme speeds the conversion of alcohol to toxic acetaldehyde. Among people of Japanese descent, those who have this form of ADH have a higher risk of pancreatic cancer than those with the more common form of ADH (Kanda et al., 2009). Research finds that genes encoding enzymes such as ADH1B involved in alcohol metabolism are polymorphic and that the superactive ADH1B*2 allele is highly prevalent (54-96%) among East Asians (Goedde et al., 1992) but relatively rare among Caucasians (1-23%). The less active ADH1B*1 is a risk factor for alcoholism in both Asians and Caucasians (Zintzaras, 2006; Zintzaras, Stefanidis, Santos, & Vidal, 2006). Some people of East Asian descent carry a variant of the gene for ALDH2 that encodes a defective form of the enzyme. In people who produce the defective enzyme, acetaldehyde builds up when they drink alcohol. The accumulation of acetaldehyde has such unpleasant effects that most people who have inherited the ALDH2 variant are unable to consume large amounts of alcohol and therefore have a low risk of developing alcohol-related cancers such as prostate cancer. Genetic differences in these enzymes suggest that the effect of alcohol consumption on prostate cancer maybe different among Asians such as Chinese from that found among Caucasians and it is thus necessary to investigate the relationship between prostate cancer and alcohol consumption in non-Caucasians, for instance in Chinese populations. There has been a marked increase in the numbers of cancers diagnosed in China between 2000 and 2011 (Chen et al., 2016). Much of this is explained by the aging and growth of the population. Other factors that may have contributed to the increase in the burden of cancer include increases in the prevalence of unhealthy behaviors or cancer‐related lifestyle and improvements in disease awareness, detection services, and data comp
中国人饮酒与前列腺癌发病率:一项系统回顾和荟萃分析
目的:荟萃分析表明,饮酒水平与前列腺癌风险之间存在剂量-反应关系,但纳入研究的人群主要是高加索人。许多中文研究没有被纳入已发表的综述和/或荟萃分析。本荟萃分析查阅了英文和中文来源的研究报告,以调查中国人之间的这种关系。方法:检索中国5个大型生物医学文献数据库,检索截至2017年5月酒精消费与前列腺癌发病率和死亡(ICD-10: C61)的病例对照和队列研究。研究根据设计、结果、饮酒者和非饮酒者、混杂控制程度和其他研究特征进行编码。混合模型用于估计由饮酒引起的前列腺癌发病率或死亡的相对风险(RR),并对设计、饮酒者偏见和饮酒者类型进行研究水平控制。研究结果:共确定了415项研究,其中25项(20项来自5个中文数据库,5项来自已发表的荟萃分析)符合纳入标准,提供了饮酒者与非饮酒者前列腺癌的36项风险评估。总共有36个OR估计;27名患者作为对照,9名健康人作为对照。9项研究(14项OR估计)将参考戒酒者定义为“从不饮酒”或“不饮酒”。校正后的RR估计表明,与不饮酒者相比,饮酒者患前列腺癌的风险显著增加(RR=1.46, 95% CI: 1.40 - 1.52, t检验P<0.001)。在评估酒精摄入水平的三项研究中,剂量-反应关系(t检验P<0.001)很明显。结论:中国饮酒者患前列腺癌的风险明显高于非饮酒者,有证据表明存在剂量-反应关系。然而,几乎所有确定的研究都存在前饮酒者和/或偶尔饮酒者的偏见。很少有研究对酒精摄入水平有足够的测量,需要进一步精心设计的研究。前列腺癌是前列腺癌的发展,前列腺是男性尿道顶部周围的一个核桃大小的腺体,产生精液(Bostwick, Crawford, Higano, & Roach, 2004)。它的生长和功能是由雄性激素如睾酮控制的。前列腺癌是全球男性中第二大常见癌症。2012年约有110万例,占男性癌症新发病例的15% (Forman & Ferlay, 2014)。它是全球男性癌症死亡的第五大常见原因。前列腺癌的发病率和死亡率在地理、种族和族裔方面存在显著差异,原因有以下几种:诊断不足、少报、筛查做法不同、获得保健服务的机会不同、知识和意识的差距以及饮酒等风险因素的流行程度(Hsing & Devesa, 2001年;Taitt, 2018)。这种疾病在高收入的西方国家最为常见,在那里筛查很普遍。然而,在亚洲国家,如日本和中国,前列腺癌的发病率似乎在增加,尽管前列腺特异性抗原(PSA)检测并不经常使用(Baade, Youlden, & Krnjacki, 2009)。IJADR International Journal of Alcohol and Drug Research The Kettil Bruun Society for Social and epidemiology Research on Alcohol 13赵金辉,高迪等––––––IJADR 8(1)––––––前列腺癌是目前中国男性的常见病。2014年男性发病率约为9.8 / 10万,自2008年以来呈明显上升趋势(中华人民共和国国家卫生健康委员会,2019;Ye & Zhu, 2015)。因此,前列腺癌作为一种慢性疾病已成为中国等发展中国家关注的重要公共卫生问题。前列腺癌的危险因素可以被认为是确定的,包括年龄、种族/民族和家族史(Gann, 2002)。许多主要在高加索人群中进行的观察性研究调查了饮酒是前列腺癌的危险因素。这些研究和评论的结论与一些发现前列腺癌风险增加的结论相矛盾(Hayes等人,1996;Sesso, Paffenbarger, & Lee, 2001;Watters, Park, Hollenbeck, Schatzkin, & Albanes, 2010),或降低风险(Dagnelie, Schuurman, Goldbohm, & Van den Brandt, 2004),其他人发现没有关系(Hiatt, Armstrong, Klatsky, & Sidney, 1994;Longnecker, 1995;莫顿,格里菲斯和布莱克洛克,1996;Stemmermann, Nomura, Chyou, & Yoshizawa, 1990;Tavani, Negri, Franceschi, Talamini, & Lavecchia, 1994;Vandergulden, Verbeek, & Kolk, 1994)。 其他可能导致癌症负担增加的因素包括不健康行为或与癌症相关的生活方式的流行程度增加,以及疾病意识、检测服务和数据比较的改善
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信